We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Masimo (NASDAQ: MASI) announced today the release of MX-7, its latest and most advanced rainbow SET board. Designed for integration into the more than 200 multi-parameter monitors available
CORCYM, the new, independent, medical device company dedicated to providing patients and cardiac surgeons with the best solutions to fight structural heart disease, announces today the enrollment of the
Pear Therapeutics has announced a merger with Thimble Point Acquisition, a special purpose acquisition company (SPAC), in a deal worth $1.6bn to go public. Founded in 2013, Pear
Quanta Dialysis Technologies has secured $245m funding in a Series D round to speed up the commercialisation of its SC+ Portable Hemodialysis System. Led by Glenview Capital and
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first patient procedure with the Hugo™ robotic-assisted surgery (RAS) system. The robotic prostatectomy was performed June 19 by
Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has received FDA 510(k) clearance for its modular collar portfolio
Surgical disposable products company Aspen Surgical Products has announced the acquisition of Stork, a division of Briggs Healthcare, for undisclosed sum. The acquisition is expected to expand Aspen’s
Los Angeles-based bioelectronics company NeuroSigma has partnered with South Korea’s telecom company KT for the development of new electronic therapies. Under the partnership, the two companies will work
PartsSource, the only evidence-based marketplace and platform that combines data-driven decision support with automation to simplify medical device products and services procurement, announced it has expanded its flagship
Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), announced today that people with diabetes who are on intensive insulin therapy, age two years or